The preparation method of bedaquiline

A technology of bedaquiline and its compound, which is applied in the field of drugs for the treatment of multidrug-resistant tuberculosis, can solve the problems of low purity of bedaquiline racemate, incomplete conversion of raw materials, and affecting the efficiency of resolution, etc., and achieves the goal of preparing Low cost, large positive progress effect and practical application value, high purity effect

Active Publication Date: 2017-09-26
CHINA NAT MEDICINES GUORUI PHARMA +1
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

There are two reasons for the low yield. One is that the α-position hydrogen of the carbonyl in compound 6 is removed under the reaction conditions, and the generated carbanion attacks the carbonyl, and various side reactions between molecules occur, resulting in very complicated reaction products; The second is due to the enolization of compound 6 (shown below), resulting in incomplete conversion of the starting material
In addition, the purity of the resulting bedaquiline racemate is not high, which seriously affects the efficiency of its resolution

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • The preparation method of bedaquiline
  • The preparation method of bedaquiline
  • The preparation method of bedaquiline

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0042] Preparation of 3-dimethylamino-2-(1-naphthyl)-prop-2-en-1-one (compound 8)

[0043] 1-Naphthyl ethyl ketone (170.0g, 1.0mol) was added to DMF-DMA (178.0g, 1.5mol) at room temperature, heated to 120°C, after 24h, cooled to room temperature, added 200ml of toluene to dilute, and then the solvent Evaporate to dryness under reduced pressure at 55°C, dilute the residue by adding 200ml of toluene, and evaporate to dryness under reduced pressure at 55°C to obtain 230.1g of yellow oil, with a crude yield of 102% and a purity of 98.5% by HPLC, which can be directly used in the next reaction .

[0044] 1 H-NMR (CDCl 3 )δ: 2.93-3.14 (m, 6H); 5.73 (d, 1H, J = 12.4Hz); 7.38-7.49 (m, 2H); 7.82 (d, 1H, J = 12.4Hz); 7.78 (m, 1H ),8.14-3.18(m,2H),8.29(d,2H,J=8.4Hz),9.45(d,2H,J=8.8Hz).ESI-MS(m / z)=226.2[M+H] +

Embodiment 2

[0046] Preparation of 3-dimethylamino-2-(1-naphthyl)-prop-2-en-1-one (compound 8)

[0047] 1-Naphthylethanone (150.0g, 0.88mol) was added to DMF-DMA (57.5g, 1.5mol) at room temperature, heated to 90°C, after 24h, cooled to room temperature, added 200ml of toluene to dilute, and then the solvent Evaporate to dryness under reduced pressure at 55°C, add 200ml of toluene to the residue to dilute, and evaporate to dryness under reduced pressure at 55°C to obtain 202.5g of yellow oil, crude yield 102%, HPLC purity 98.8%. ESI-MS(m / z)=226.2[M+H] +

Embodiment 3

[0049] Preparation of 3-dimethylamino-2-(1-naphthyl)-prop-2-en-1-one (compound 8)

[0050] 1-Naphthyl ethyl ketone (250.0g, 1.47mol) was added to DMF-DMA (262.5g, 2.20mol) at room temperature, heated to 90°C, after 48h, cooled to room temperature, added 200ml of toluene to dilute, and then the solvent Evaporate to dryness under reduced pressure at 55°C, add 200ml of toluene to the residue to dilute, and evaporate to dryness under reduced pressure at 55°C to obtain 334.2g of yellow oil with a crude yield of 101% and an HPLC purity of 98.2%. ESI-MS(m / z)=226.2[M+H] +

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a preparation method for bedaquiline. The preparation method comprises the following steps: enabling a compound (9) to be reacted with a reducing agent in a solvent; and then collecting racemate of bedaquiline from a reaction product. The preparation method has the advantages that the compound (9) is a novel compound which has not been reported in literature; the racemate of bedaquiline is prepared from a compound (8) and the compound (9); the obtained product is greatly increased in yield (greater than 47%) which is remarkably greater than the yield (26%) in the original patent; and the obtained racemate of bedaquiline is high in purity, stable and controllable in quality, and beneficial for subsequent resolution reaction, and has relatively great positive effects and relatively high practical application value. The reaction formula is shown as follows: a FORMULA as shown in the description.

Description

technical field [0001] The invention relates to a drug bedaquiline ((1R,2S)-1-(6-bromo-2-methoxyquinoline-3-)-4-dimethylamino-1- Preparation method of phenyl-2-(1-naphthyl)-2-butanol) racemate. Background technique [0002] Tuberculosis is a chronic infectious disease caused by Mycobacterium tuberculosis, which can affect multiple organ systems throughout the body. According to the statistics of the World Health Organization, about 1 / 3 of the world's population is infected with Mycobacterium tuberculosis every year and about 3,800 people die of tuberculosis every day [Curr Opin Immunol, 2011,23(4):464-472.]. Tuberculosis has become one of the major diseases that seriously threaten human health in the 21st century. [0003] The main reason for the worldwide spread of tuberculosis is the strong viability of Mycobacterium tuberculosis. In fact, Mycobacterium tuberculosis, as one of the most threatening pathogens, has evolved a series of mechanisms to counteract the host's im...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C07D215/227
CPCC07D215/227
Inventor 李建其刘育邴绍昌吴夏冰周爱南黄雷金仁力王健蒋敏王磊
Owner CHINA NAT MEDICINES GUORUI PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap